Amyloid β peptide-induced corpus callosum damage and glial activation in vivo

被引:78
作者
Jantaratnotai, N
Ryu, JK
Kim, SU
McLarnon, JG
机构
[1] Univ British Columbia, Fac Med, Dept Pharmacol, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Fac Med, Dept Therapeut, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC V6T 1Z3, Canada
[4] Ajou Univ, Brain Dis Res Ctr, Suwon 441749, South Korea
关键词
Alzheimer's disease; amyloid beta-pepticle; astrocytes; corpus callosum; microglia; myelin; neurofilament; oligodendrocytes;
D O I
10.1097/00001756-200308060-00005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effects of stereotaxic injection of annyloid beta-peptide (Abeta(1-42)) into rat brain to induce white matter damage have been studied. Administration of I nmol Abeta(1-42) into corpus callosum resulted in considerable damage to axons as evidenced by the loss of neurofilament-immunoreactive (NF-ir) fibers 6 h and 3 and 7 days post-injection. Significant damage was also evident to myelin (using Luxol fast blue myelin staining) and oligodendrocytes (using CCI immunocytochemistry); in the latter case marked caspase-3 immunoreactivity was evident in oligodendrocytes. Additionally, the numbers of GFAP-ir astrocytes and OX-42/OX-6-ir microglia were markedly increased following Abeta(1-42) injection. These results suggest that A plays an important pathophysiological role in white matter damage and that inflammatory responses may contribute to Abeta-induced demyelination and oligodendrocyte injury in corpus callosum. Loss of function of cells in corpus callosum could provide a potential new model for the study of white matter damage in Alzheimer's disease.
引用
收藏
页码:1429 / 1433
页数:5
相关论文
共 26 条
[1]   HUMAN CORPUS-CALLOSUM IN AGING AND ALZHEIMERS-DISEASE - A MAGNETIC-RESONANCE-IMAGING STUDY [J].
BIEGON, A ;
EBERLING, JL ;
RICHARDSON, BC ;
ROOS, MS ;
WONG, STS ;
REED, BR ;
JAGUST, WJ .
NEUROBIOLOGY OF AGING, 1994, 15 (04) :393-397
[2]   A WHITE MATTER DISORDER IN DEMENTIA OF THE ALZHEIMER TYPE - A PATHOANATOMICAL STUDY [J].
BRUN, A ;
ENGLUND, E .
ANNALS OF NEUROLOGY, 1986, 19 (03) :253-262
[3]   QUANTITATION OF CEREBRAL ATROPHY IN PRECLINICAL AND END-STAGE ALZHEIMERS-DISEASE [J].
DELAMONTE, SM .
ANNALS OF NEUROLOGY, 1989, 25 (05) :450-459
[4]   In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease -: Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy.: Evidence from studies with MRI, EEG and PET [J].
Hampel, H ;
Teipel, SJ ;
Alexander, GE ;
Pogarell, O ;
Rapoport, SI ;
Möller, HJ .
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (5-6) :837-855
[5]   Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease [J].
Holtzman, DM ;
Bales, KR ;
Tenkova, T ;
Fagan, AM ;
Parsadanian, M ;
Sartorius, LJ ;
Mackey, B ;
Olney, J ;
McKeel, D ;
Wozniak, D ;
Paul, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2892-2897
[6]   Distribution of amyloid deposits in the cerebral white matter of the Alzheimer's disease brain: Relationship to blood vessels [J].
Iwamoto, N ;
Nishiyama, E ;
Ohwada, J ;
Arai, H .
ACTA NEUROPATHOLOGICA, 1997, 93 (04) :334-340
[7]   Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging [J].
Janowsky, JS ;
Kaye, JA ;
Carper, RA .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (07) :798-803
[8]   Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease [J].
Kobayashi, K ;
Hayashi, M ;
Nakano, H ;
Fukutani, Y ;
Sasaki, K ;
Shimazaki, M ;
Koshino, Y .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2002, 28 (03) :238-251
[9]   CELL-DEATH IN ALZHEIMERS-DISEASE EVALUATED BY DNA FRAGMENTATION IN-SITU [J].
LASSMANN, H ;
BANCHER, C ;
BREITSCHOPF, H ;
WEGIEL, J ;
BOBINSKI, M ;
JELLINGER, K ;
WISNIEWSKI, HM .
ACTA NEUROPATHOLOGICA, 1995, 89 (01) :35-41
[10]   Inactivation of Rho signaling pathway promotes CNS axon regeneration [J].
Lehmann, M ;
Fournier, A ;
Selles-Navarro, I ;
Dergham, P ;
Sebok, A ;
Leclerc, N ;
Tigyi, G ;
McKerracher, L .
JOURNAL OF NEUROSCIENCE, 1999, 19 (17) :7537-7547